Cited by 199Parkinson's Disease Mechanisms and TreatmentsMitochondrial Function and PathologyNuclear Receptors and Signaling

Uncoupling Protein-2 Is Critical for Nigral Dopamine Cell Survival in a Mouse Model of Parkinson's Disease

Open access
Andrews, Zane B., Horvath, Balazs, Barnstable, Colin J., Elseworth, John, Yang, Lichuan, Beal, M. Flynt, Roth, Robert H., Matthews, Russell T. +1 more·2005·The Journal of Neuroscience

Abstract

Mitochondrial uncoupling proteins dissociate ATP synthesis from oxygen consumption in mitochondria and suppress free-radical production. We show that genetic manipulation of uncoupling protein-2 (UCP2) directly affects substantia nigra dopamine cell function. Overexpression of UCP2 increases mitochondrial uncoupling, whereas deletion of UCP2 reduces uncoupling in the substantia nigra-ventral tegmental area. Overexpression of UCP2 decreased reactive oxygen species (ROS) production, which was measured using dihydroethidium because it is specifically oxidized to fluorescent ethidium by the superoxide anion, whereas mice lacking UCP2 exhibited increased ROS relative to wild-type controls. Unbiased electron microscopic analysis revealed that the elevation of in situ mitochondrial ROS production in UCP2 knock-out mice was inversely correlated with mitochondria number in dopamine neurons. Lack of UCP2 increased the sensitivity of dopamine neurons to 1-methyl-4-phenyl-1,2,5,6 tetrahydropyridine (MPTP), whereas UCP2 overexpression decreased MPTP-induced nigral dopamine cell loss. The present results expose the critical importance of UCP2 in normal nigral dopamine cell metabolism and offer a novel therapeutic target, UCP2, for the prevention/treatment of Parkinson's disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.4269-04.2005

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • UCP2 helps preserve dopamine neurons in a mouse model of Parkinson disease due, in part, to its ability to reduce ROS production.

    “Other studies, however, suggest that UCP2 helps to preserve dopamine neurons in a mouse model of Parkinson disease due, in part, to its ability to reduce ROS production: in this model deficient mice had more ROS and increased cell loss compared to wild-type controls, whereas UCP2 overexpressing mice were more protected with less ROS and less cell death (12).”

    From Redox regulation of mitochondrial function (2012) · cites this paper as [12]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 32 · Cited by 199

Authors
Andrews, Z. B., Horvath, B., Barnstable, C. J., Elseworth, J., Yang, L., Beal, M. F., Roth, R. H., Matthews, R. T., & Horvath, T. L.
Affiliations
  • Yale University (US)
  • Cornell University (US)
Venue
The Journal of Neuroscience
Published
2005-01-05
Volume
25
Issue
1
Pages
184-191
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2062344501
Cited by
199
References
32
Citations by year
2026: 1 · 2025: 5 · 2024: 4 · 2023: 3 · 2022: 7 · 2021: 5 · 2020: 6 · 2019: 5 · 2018: 9 · 2017: 11 · 2016: 11 · 2015: 9 · 2014: 13 · 2013: 9 · 2012: 22
FWCI
9.09
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (R01 NS)
  • National Institute of Neurological Disorders and Stroke (R01NS041725, R01 NS-41725)
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
Keywords
UCP2, Parkinson's disease, substantia nigra, dopaminergic neurons, mitochondrial uncoupling, reactive oxygen species, superoxide, MPTP-induced neurotoxicity, UCP2 knockout mice, mitochondrial number, therapeutic target
MeSH terms
Uncoupling Protein 2, Animals, Cell Survival, Corpus Striatum, Disease Models, Animal, Dopamine, Humans, Immunohistochemistry, Ion Channels, Male, Mice, Inbred C57BL, Mice, Transgenic, Mitochondria, Oxygen Consumption, Substantia Nigra, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 1-Methyl-4-phenylpyridinium, Reactive Oxygen Species, Mice, Knockout, Parkinsonian Disorders, Mitochondrial Proteins, Membrane Transport Proteins, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review